How long does Wegovy take to produce weight loss? The evidence explained

What the STEP 1 trial tells us about early versus later weight loss

The STEP 1 trial tracked weight change week by week, and the pattern it showed is consistent: weight loss begins within the first month, but the steepest decline happens between roughly weeks 12 and 44. Participants who reached the full 2.4mg maintenance dose saw their rate of loss accelerate once semaglutide's appetite-reducing effects were fully established at that level.

In practical terms, most people notice some change (reduced hunger, slightly smaller portions feeling adequate) within the first two to four weeks. The scales tend to move more meaningfully once the dose climbs above 1mg. By around the six-month mark, many participants in the trial had lost roughly half of their total eventual weight loss. The second half accumulates more slowly as the body adjusts.

It is worth reading the NHS patient information on semaglutide alongside the trial data, because it sets clear expectations: this is a long-term medicine, not a short course. The NICE recommendation for semaglutide (TA875) includes a review point at six months on the maintenance dose, if less than 5% weight loss has occurred by then, continuing treatment is reconsidered. That review point underlines why patience through the titration phase matters.

The titration schedule and why it shapes the time frame

A question our prescribers hear most weeks is some version of: "I've been on it a month and I've only lost a couple of pounds, is that normal?" Almost always, the person is still in the early titration stage, at 0.25mg or 0.5mg, where the dose is designed primarily to let the body adjust rather than to deliver maximum weight loss. Nausea and other gastrointestinal effects are most noticeable here, and pushing through this period calmly is part of what allows the full treatment effect to develop later.

The licensed titration pathway for Wegovy moves through 0.25mg, 0.5mg, 1.0mg, 1.7mg and 2.4mg, with roughly four weeks at each level before the next step. That means reaching the standard maintenance dose takes around 16 to 20 weeks from the first injection. If a dose increase causes side effects that don't settle, the prescriber may hold at the current dose for longer, which extends the overall time frame but is the right clinical call. Rushing the titration to chase faster results tends to produce worse tolerability, not better outcomes.

If you are curious about when to take your weekly injection to fit your routine, consistency of timing each week matters more than the specific hour chosen.

Realistic expectations at three, six and twelve months

Trial data gives us a useful scaffold, but it describes averages. Individual results sit across a wide range on either side. With that caveat stated plainly, here is what the evidence broadly suggests across the time frame:

By three months, most people using Wegovy have completed roughly half the titration steps and are beginning to see more consistent weight loss. If you want to understand how long Wegovy typically takes to produce meaningful results, published analyses suggest an average reduction of around 5 to 8% of starting weight by this point, though responses range considerably.

By six months (typically the first time a formal clinical review considers whether the treatment is working) average losses in trials were in the region of 10 to 12%. This is also the threshold point referenced in NICE's appraisal of semaglutide (TA875): a clinical review assesses whether loss has reached 5% on the maintenance dose.

The full 68-week STEP 1 average of around 15% loss was reached by participants who stayed on treatment, reached 2.4mg, and combined it with dietary and activity changes. The MHRA has approved a higher 7.2mg dose of Wegovy, and if you want to understand how results build over time, reading about the Wegovy weight loss timeline can help you see what to expect at each stage, including trial data showing around 20.7% average weight loss over 72 weeks at that level, though individual prescribing decisions about dose are always made by the clinician. Understanding how much weight loss people typically achieve with Wegovy can help set a realistic personal target before you begin.

For a fuller picture of how semaglutide works and what treatment involves, our Wegovy overview covers the mechanism, eligibility and what to expect from the process. If you are comparing Wegovy with other licensed options, the weight loss treatments page sets out what is available through a private prescription in the UK.

Cost is a practical consideration for most people planning a course of treatment that may last a year or longer. The Wegovy pricing page explains what a private prescription typically involves and what the single price at nume covers, without any subscription commitment.

When you are ready to find out whether Wegovy is clinically suitable for you, a prescriber at our GPhC-registered pharmacy will review your consultation the same day, no algorithm, a real clinician reading your answers. Start your free consultation and get a clinical answer, not a guess.